Owners
Puridify Limited — the company created based on University College London which is engaged in development of biotechnologies for industrial production. Puridify founded in 2013 develops technology of purification of substances on the basis of FibroSelect nanofibres which found application in biopharmaceutical industry.
The technology was developed in 2013 in department of biochemical engineering of University College London, one of the leading research centers of Great Britain. The UCLB company which promotes the innovation and potentially effective technologies developed in this college acted as the investor of Puridify Limited. Besides, made investments of Touchstone Innovations and SR One in development of the platform of cleaning.
2017: GE Healthcare buys Puridify
On December 1, 2017 the American producer of the medical equipment GE Healthcare announced Puridify Limited acquisition. The cost of the transaction does not reveal.
It is supposed that the FibroSelect platform thanks to GE Healthcare will improve performance at a development stage of process and small-lot biopharmaceutical production. The GE Healthcare company is ready to invest in it even more means to bring the platform to mass market and completely to integrate into devices of cleaning of the company. Such technology will allow to reduce the cost of purification of pharmaceutical substances and to accelerate postprocessing process.[1]
According to experts, the new, improved technologies of cleaning as the speed of the previous processing stages of substances significantly grew recently are required for this branch of the industry, and slow cleaning brakes all production process.
Development of Puridify should solve this problem as the invention of the company joins ranks of such biopharmaceutical technologies as use of ion-exchange pitches and membrane chromotography. The technology should provide faster transfer of substances, i.e. big efficiency and also it is easy to be regulated and adapt to different conditions of production.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |